Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Elevance Health Inc.
Elevance Health Inc. News
Jun 22, 2025 - globenewswire.com
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
Jun 22, 2025 - prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Jun 22, 2025 - globenewswire.com
ELV FRAUD ALERT: Elevance Health, Inc. Investors are Reminded of Ongoing Securities Fraud Class Action -- Contact BFA Law by July 11 Legal Deadline (NYSE:ELV)
Jun 20, 2025 - prnewswire.com
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Elevance Health Inc. Quantitative Score
About Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Elevance Health Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Elevance Health Inc. Financials
Table Compare
Compare ELV metrics with: | |||
|---|---|---|---|
Earnings & Growth | ELV | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ELV | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ELV | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ELV | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Elevance Health Inc. Income
Elevance Health Inc. Balance Sheet
Elevance Health Inc. Cash Flow
Elevance Health Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Elevance Health Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 6.6800 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-06-25 | 1.71 | Quarterly |
| 2025-03-25 | 1.71 | Quarterly |
| 2024-12-20 | 1.63 | Quarterly |
| 2024-09-25 | 1.63 | Quarterly |
| 2024-06-25 | 1.63 | Quarterly |
Historical Market Cap
Shares Outstanding
Elevance Health Inc. Executives
| Name | Role |
|---|---|
| Ms. Gail Koziara Boudreaux | President, Chief Executive Officer & Director |
| Mr. Blair Williams Todt | Executive Vice President and Chief Legal & Administrative Officer |
| Mr. Peter David Haytaian Esq. | Executive Vice President and President of Carelon & CarelonRx |
| Mr. Charles Morgan Kendrick Jr. | Executive Vice President & President of Commercial Health Benefits |
| Ms. Felicia Farr Norwood | Executive Vice President & President of Government Health Benefits |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Ms. Gail Koziara Boudreaux | President, Chief Executive Officer & Director | Female | 1961 | 3.67M |
| Mr. Blair Williams Todt | Executive Vice President and Chief Legal & Administrative Officer | Male | 1968 | 2.11M |
| Mr. Peter David Haytaian Esq. | Executive Vice President and President of Carelon & CarelonRx | Male | 1970 | 1.55M |
| Mr. Charles Morgan Kendrick Jr. | Executive Vice President & President of Commercial Health Benefits | Male | 1966 | 1.49M |
| Ms. Felicia Farr Norwood | Executive Vice President & President of Government Health Benefits | Female | 1960 | 1.49M |
Elevance Health Inc. Insider Trades
| Date | 14 May |
| Name | STRABLE-SOETHOUT DEANNA D |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 601 |
| Date | 14 May |
| Name | Schneider Ryan M. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 601 |
| Date | 14 May |
| Name | PERU RAMIRO G |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 601 |
| Date | 14 May |
| Name | Neri Antonio F |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 601 |
| Date | 14 May |
| Name | Jallal Bahija |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 601 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 14 May | STRABLE-SOETHOUT DEANNA D | Director | Acquired | A-Award | 601 |
| 14 May | Schneider Ryan M. | Director | Acquired | A-Award | 601 |
| 14 May | PERU RAMIRO G | Director | Acquired | A-Award | 601 |
| 14 May | Neri Antonio F | Director | Acquired | A-Award | 601 |
| 14 May | Jallal Bahija | Director | Acquired | A-Award | 601 |